Global Endometriosis Drugs Market Insights and Forecast to 2031

Report ID: 1665900 | Published Date: Jan 2025 | No. of Page: 111 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Endometriosis Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Hormonal Therapy
        1.2.3 Add-back Medication
        1.2.4 Progestogens
        1.2.5 Chinese Herbs
    1.3 Market by Application
        1.3.1 Global Endometriosis Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Research Institutes
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Endometriosis Drugs Market Perspective (2017-2028)
    2.2 Endometriosis Drugs Growth Trends by Region
        2.2.1 Endometriosis Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Endometriosis Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Endometriosis Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Endometriosis Drugs Market Dynamics
        2.3.1 Endometriosis Drugs Industry Trends
        2.3.2 Endometriosis Drugs Market Drivers
        2.3.3 Endometriosis Drugs Market Challenges
        2.3.4 Endometriosis Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Endometriosis Drugs Players by Revenue
        3.1.1 Global Top Endometriosis Drugs Players by Revenue (2017-2022)
        3.1.2 Global Endometriosis Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Endometriosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Endometriosis Drugs Revenue
    3.4 Global Endometriosis Drugs Market Concentration Ratio
        3.4.1 Global Endometriosis Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Endometriosis Drugs Revenue in 2021
    3.5 Endometriosis Drugs Key Players Head office and Area Served
    3.6 Key Players Endometriosis Drugs Product Solution and Service
    3.7 Date of Enter into Endometriosis Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Endometriosis Drugs Breakdown Data by Type
    4.1 Global Endometriosis Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Endometriosis Drugs Forecasted Market Size by Type (2023-2028)
5 Endometriosis Drugs Breakdown Data by Application
    5.1 Global Endometriosis Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Endometriosis Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Endometriosis Drugs Market Size (2017-2028)
    6.2 North America Endometriosis Drugs Market Size by Type
        6.2.1 North America Endometriosis Drugs Market Size by Type (2017-2022)
        6.2.2 North America Endometriosis Drugs Market Size by Type (2023-2028)
        6.2.3 North America Endometriosis Drugs Market Share by Type (2017-2028)
    6.3 North America Endometriosis Drugs Market Size by Application
        6.3.1 North America Endometriosis Drugs Market Size by Application (2017-2022)
        6.3.2 North America Endometriosis Drugs Market Size by Application (2023-2028)
        6.3.3 North America Endometriosis Drugs Market Share by Application (2017-2028)
    6.4 North America Endometriosis Drugs Market Size by Country
        6.4.1 North America Endometriosis Drugs Market Size by Country (2017-2022)
        6.4.2 North America Endometriosis Drugs Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Endometriosis Drugs Market Size (2017-2028)
    7.2 Europe Endometriosis Drugs Market Size by Type
        7.2.1 Europe Endometriosis Drugs Market Size by Type (2017-2022)
        7.2.2 Europe Endometriosis Drugs Market Size by Type (2023-2028)
        7.2.3 Europe Endometriosis Drugs Market Share by Type (2017-2028)
    7.3 Europe Endometriosis Drugs Market Size by Application
        7.3.1 Europe Endometriosis Drugs Market Size by Application (2017-2022)
        7.3.2 Europe Endometriosis Drugs Market Size by Application (2023-2028)
        7.3.3 Europe Endometriosis Drugs Market Share by Application (2017-2028)
    7.4 Europe Endometriosis Drugs Market Size by Country
        7.4.1 Europe Endometriosis Drugs Market Size by Country (2017-2022)
        7.4.2 Europe Endometriosis Drugs Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Endometriosis Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Endometriosis Drugs Market Size by Type
        8.2.1 Asia-Pacific Endometriosis Drugs Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Endometriosis Drugs Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Endometriosis Drugs Market Share by Type (2017-2028)
    8.3 Asia-Pacific Endometriosis Drugs Market Size by Application
        8.3.1 Asia-Pacific Endometriosis Drugs Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Endometriosis Drugs Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Endometriosis Drugs Market Share by Application (2017-2028)
    8.4 Asia-Pacific Endometriosis Drugs Market Size by Region
        8.4.1 Asia-Pacific Endometriosis Drugs Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Endometriosis Drugs Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Endometriosis Drugs Market Size (2017-2028)
    9.2 Latin America Endometriosis Drugs Market Size by Type
        9.2.1 Latin America Endometriosis Drugs Market Size by Type (2017-2022)
        9.2.2 Latin America Endometriosis Drugs Market Size by Type (2023-2028)
        9.2.3 Latin America Endometriosis Drugs Market Share by Type (2017-2028)
    9.3 Latin America Endometriosis Drugs Market Size by Application
        9.3.1 Latin America Endometriosis Drugs Market Size by Application (2017-2022)
        9.3.2 Latin America Endometriosis Drugs Market Size by Application (2023-2028)
        9.3.3 Latin America Endometriosis Drugs Market Share by Application (2017-2028)
    9.4 Latin America Endometriosis Drugs Market Size by Country
        9.4.1 Latin America Endometriosis Drugs Market Size by Country (2017-2022)
        9.4.2 Latin America Endometriosis Drugs Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Endometriosis Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Endometriosis Drugs Market Size by Type
        10.2.1 Middle East & Africa Endometriosis Drugs Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Endometriosis Drugs Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Endometriosis Drugs Market Share by Type (2017-2028)
    10.3 Middle East & Africa Endometriosis Drugs Market Size by Application
        10.3.1 Middle East & Africa Endometriosis Drugs Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Endometriosis Drugs Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Endometriosis Drugs Market Share by Application (2017-2028)
    10.4 Middle East & Africa Endometriosis Drugs Market Size by Country
        10.4.1 Middle East & Africa Endometriosis Drugs Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Endometriosis Drugs Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 AbbVie
        11.1.1 AbbVie Company Details
        11.1.2 AbbVie Business Overview
        11.1.3 AbbVie Endometriosis Drugs Introduction
        11.1.4 AbbVie Revenue in Endometriosis Drugs Business (2017-2022)
        11.1.5 AbbVie Recent Developments
    11.2 Astellas Pharma
        11.2.1 Astellas Pharma Company Details
        11.2.2 Astellas Pharma Business Overview
        11.2.3 Astellas Pharma Endometriosis Drugs Introduction
        11.2.4 Astellas Pharma Revenue in Endometriosis Drugs Business (2017-2022)
        11.2.5 Astellas Pharma Recent Developments
    11.3 AstraZeneca
        11.3.1 AstraZeneca Company Details
        11.3.2 AstraZeneca Business Overview
        11.3.3 AstraZeneca Endometriosis Drugs Introduction
        11.3.4 AstraZeneca Revenue in Endometriosis Drugs Business (2017-2022)
        11.3.5 AstraZeneca Recent Developments
    11.4 Debiopharm Group
        11.4.1 Debiopharm Group Company Details
        11.4.2 Debiopharm Group Business Overview
        11.4.3 Debiopharm Group Endometriosis Drugs Introduction
        11.4.4 Debiopharm Group Revenue in Endometriosis Drugs Business (2017-2022)
        11.4.5 Debiopharm Group Recent Developments
    11.5 Evotec
        11.5.1 Evotec Company Details
        11.5.2 Evotec Business Overview
        11.5.3 Evotec Endometriosis Drugs Introduction
        11.5.4 Evotec Revenue in Endometriosis Drugs Business (2017-2022)
        11.5.5 Evotec Recent Developments
    11.6 Kissei Pharmaceutical
        11.6.1 Kissei Pharmaceutical Company Details
        11.6.2 Kissei Pharmaceutical Business Overview
        11.6.3 Kissei Pharmaceutical Endometriosis Drugs Introduction
        11.6.4 Kissei Pharmaceutical Revenue in Endometriosis Drugs Business (2017-2022)
        11.6.5 Kissei Pharmaceutical Recent Developments
    11.7 Neurocrine Biosciences
        11.7.1 Neurocrine Biosciences Company Details
        11.7.2 Neurocrine Biosciences Business Overview
        11.7.3 Neurocrine Biosciences Endometriosis Drugs Introduction
        11.7.4 Neurocrine Biosciences Revenue in Endometriosis Drugs Business (2017-2022)
        11.7.5 Neurocrine Biosciences Recent Developments
    11.8 ObsEva
        11.8.1 ObsEva Company Details
        11.8.2 ObsEva Business Overview
        11.8.3 ObsEva Endometriosis Drugs Introduction
        11.8.4 ObsEva Revenue in Endometriosis Drugs Business (2017-2022)
        11.8.5 ObsEva Recent Developments
    11.9 Pfizer
        11.9.1 Pfizer Company Details
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Endometriosis Drugs Introduction
        11.9.4 Pfizer Revenue in Endometriosis Drugs Business (2017-2022)
        11.9.5 Pfizer Recent Developments
    11.10 Repros Therapeutics
        11.10.1 Repros Therapeutics Company Details
        11.10.2 Repros Therapeutics Business Overview
        11.10.3 Repros Therapeutics Endometriosis Drugs Introduction
        11.10.4 Repros Therapeutics Revenue in Endometriosis Drugs Business (2017-2022)
        11.10.5 Repros Therapeutics Recent Developments
    11.11 Roivant Sciences
        11.11.1 Roivant Sciences Company Details
        11.11.2 Roivant Sciences Business Overview
        11.11.3 Roivant Sciences Endometriosis Drugs Introduction
        11.11.4 Roivant Sciences Revenue in Endometriosis Drugs Business (2017-2022)
        11.11.5 Roivant Sciences Recent Developments
    11.12 Takeda Pharmaceutical Company
        11.12.1 Takeda Pharmaceutical Company Company Details
        11.12.2 Takeda Pharmaceutical Company Business Overview
        11.12.3 Takeda Pharmaceutical Company Endometriosis Drugs Introduction
        11.12.4 Takeda Pharmaceutical Company Revenue in Endometriosis Drugs Business (2017-2022)
        11.12.5 Takeda Pharmaceutical Company Recent Developments
    11.13 ValiRx
        11.13.1 ValiRx Company Details
        11.13.2 ValiRx Business Overview
        11.13.3 ValiRx Endometriosis Drugs Introduction
        11.13.4 ValiRx Revenue in Endometriosis Drugs Business (2017-2022)
        11.13.5 ValiRx Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Endometriosis Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Hormonal Therapy
    Table 3. Key Players of Add-back Medication
    Table 4. Key Players of Progestogens
    Table 5. Key Players of Chinese Herbs
    Table 6. Global Endometriosis Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Endometriosis Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Endometriosis Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Endometriosis Drugs Market Share by Region (2017-2022)
    Table 10. Global Endometriosis Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Endometriosis Drugs Market Share by Region (2023-2028)
    Table 12. Endometriosis Drugs Market Trends
    Table 13. Endometriosis Drugs Market Drivers
    Table 14. Endometriosis Drugs Market Challenges
    Table 15. Endometriosis Drugs Market Restraints
    Table 16. Global Endometriosis Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Endometriosis Drugs Revenue Share by Players (2017-2022)
    Table 18. Global Top Endometriosis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometriosis Drugs as of 2021)
    Table 19. Ranking of Global Top Endometriosis Drugs Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Endometriosis Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Endometriosis Drugs Product Solution and Service
    Table 23. Date of Enter into Endometriosis Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Endometriosis Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Endometriosis Drugs Revenue Market Share by Type (2017-2022)
    Table 27. Global Endometriosis Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Endometriosis Drugs Revenue Market Share by Type (2023-2028)
    Table 29. Global Endometriosis Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Endometriosis Drugs Revenue Share by Application (2017-2022)
    Table 31. Global Endometriosis Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Endometriosis Drugs Revenue Share by Application (2023-2028)
    Table 33. North America Endometriosis Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Endometriosis Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Endometriosis Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Endometriosis Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Endometriosis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Endometriosis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Endometriosis Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Endometriosis Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Endometriosis Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Endometriosis Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Endometriosis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Endometriosis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Endometriosis Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Endometriosis Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Endometriosis Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Endometriosis Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Endometriosis Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Endometriosis Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Endometriosis Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Endometriosis Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Endometriosis Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Endometriosis Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Endometriosis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Endometriosis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Endometriosis Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Endometriosis Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Endometriosis Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Endometriosis Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Endometriosis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Endometriosis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 63. AbbVie Company Details
    Table 64. AbbVie Business Overview
    Table 65. AbbVie Endometriosis Drugs Product
    Table 66. AbbVie Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
    Table 67. AbbVie Recent Developments
    Table 68. Astellas Pharma Company Details
    Table 69. Astellas Pharma Business Overview
    Table 70. Astellas Pharma Endometriosis Drugs Product
    Table 71. Astellas Pharma Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
    Table 72. Astellas Pharma Recent Developments
    Table 73. AstraZeneca Company Details
    Table 74. AstraZeneca Business Overview
    Table 75. AstraZeneca Endometriosis Drugs Product
    Table 76. AstraZeneca Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
    Table 77. AstraZeneca Recent Developments
    Table 78. Debiopharm Group Company Details
    Table 79. Debiopharm Group Business Overview
    Table 80. Debiopharm Group Endometriosis Drugs Product
    Table 81. Debiopharm Group Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
    Table 82. Debiopharm Group Recent Developments
    Table 83. Evotec Company Details
    Table 84. Evotec Business Overview
    Table 85. Evotec Endometriosis Drugs Product
    Table 86. Evotec Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
    Table 87. Evotec Recent Developments
    Table 88. Kissei Pharmaceutical Company Details
    Table 89. Kissei Pharmaceutical Business Overview
    Table 90. Kissei Pharmaceutical Endometriosis Drugs Product
    Table 91. Kissei Pharmaceutical Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
    Table 92. Kissei Pharmaceutical Recent Developments
    Table 93. Neurocrine Biosciences Company Details
    Table 94. Neurocrine Biosciences Business Overview
    Table 95. Neurocrine Biosciences Endometriosis Drugs Product
    Table 96. Neurocrine Biosciences Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
    Table 97. Neurocrine Biosciences Recent Developments
    Table 98. ObsEva Company Details
    Table 99. ObsEva Business Overview
    Table 100. ObsEva Endometriosis Drugs Product
    Table 101. ObsEva Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
    Table 102. ObsEva Recent Developments
    Table 103. Pfizer Company Details
    Table 104. Pfizer Business Overview
    Table 105. Pfizer Endometriosis Drugs Product
    Table 106. Pfizer Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
    Table 107. Pfizer Recent Developments
    Table 108. Repros Therapeutics Company Details
    Table 109. Repros Therapeutics Business Overview
    Table 110. Repros Therapeutics Endometriosis Drugs Product
    Table 111. Repros Therapeutics Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
    Table 112. Repros Therapeutics Recent Developments
    Table 113. Roivant Sciences Company Details
    Table 114. Roivant Sciences Business Overview
    Table 115. Roivant Sciences Endometriosis Drugs Product
    Table 116. Roivant Sciences Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
    Table 117. Roivant Sciences Recent Developments
    Table 118. Takeda Pharmaceutical Company Company Details
    Table 119. Takeda Pharmaceutical Company Business Overview
    Table 120. Takeda Pharmaceutical Company Endometriosis Drugs Product
    Table 121. Takeda Pharmaceutical Company Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
    Table 122. Takeda Pharmaceutical Company Recent Developments
    Table 123. ValiRx Company Details
    Table 124. ValiRx Business Overview
    Table 125. ValiRx Endometriosis Drugs Product
    Table 126. ValiRx Revenue in Endometriosis Drugs Business (2017-2022) & (US$ Million)
    Table 127. ValiRx Recent Developments
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Endometriosis Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Hormonal Therapy Features
    Figure 3. Add-back Medication Features
    Figure 4. Progestogens Features
    Figure 5. Chinese Herbs Features
    Figure 6. Global Endometriosis Drugs Market Share by Application: 2021 VS 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Research Institutes Case Studies
    Figure 10. Endometriosis Drugs Report Years Considered
    Figure 11. Global Endometriosis Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Endometriosis Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Endometriosis Drugs Market Share by Region: 2021 VS 2028
    Figure 14. Global Endometriosis Drugs Market Share by Players in 2021
    Figure 15. Global Top Endometriosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometriosis Drugs as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Endometriosis Drugs Revenue in 2021
    Figure 17. North America Endometriosis Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Endometriosis Drugs Market Size Market Share by Type (2017-2028)
    Figure 19. North America Endometriosis Drugs Market Size Market Share by Application (2017-2028)
    Figure 20. North America Endometriosis Drugs Market Size Share by Country (2017-2028)
    Figure 21. United States Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Endometriosis Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Endometriosis Drugs Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Endometriosis Drugs Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Endometriosis Drugs Market Size Share by Country (2017-2028)
    Figure 27. Germany Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Endometriosis Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Endometriosis Drugs Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Endometriosis Drugs Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Endometriosis Drugs Market Size Share by Region (2017-2028)
    Figure 37. China Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Endometriosis Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Endometriosis Drugs Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Endometriosis Drugs Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Endometriosis Drugs Market Size Share by Country (2017-2028)
    Figure 47. Mexico Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Endometriosis Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Endometriosis Drugs Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Endometriosis Drugs Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Endometriosis Drugs Market Size Share by Country (2017-2028)
    Figure 53. Turkey Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Endometriosis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. AbbVie Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
    Figure 57. Astellas Pharma Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
    Figure 58. AstraZeneca Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
    Figure 59. Debiopharm Group Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
    Figure 60. Evotec Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
    Figure 61. Kissei Pharmaceutical Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
    Figure 62. Neurocrine Biosciences Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
    Figure 63. ObsEva Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
    Figure 64. Pfizer Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
    Figure 65. Repros Therapeutics Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
    Figure 66. Roivant Sciences Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
    Figure 67. Takeda Pharmaceutical Company Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
    Figure 68. ValiRx Revenue Growth Rate in Endometriosis Drugs Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie
Astellas Pharma
AstraZeneca
Debiopharm Group
Evotec
Kissei Pharmaceutical
Neurocrine Biosciences
ObsEva
Pfizer
Repros Therapeutics
Roivant Sciences
Takeda Pharmaceutical Company
ValiRx
Frequently Asked Questions
Endometriosis Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Endometriosis Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Endometriosis Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Energy Management

Energy Management market is segmented by players, region (country), by Type and by Application. P ... Read More